Mohamed AbdAllah

Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real‐world results from 18 378 patients in Egypt

Heba Omar, Wafaa Elakel, Tamer Elbaz et al. · Alimentary Pharmacology & Therapeutics · 2017 · 124 citations · Full text

Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon

Aisha Elsharkawy, Shereen Abdel Alem, Rabab Fouad et al. · Journal of Gastroenterology and Hepatology · 2017 · 91 citations

Impact of different sofosbuvir based treatment regimens on the biochemical profile of chronic hepatitis C genotype 4 patients

Aisha Elsharkawy, Rasha Eletreby, Rabab Fouad et al. · Expert Review of Gastroenterology & Hepatology · 2017 · 42 citations

Pattern and determinants of COVID-19 infection and mortality across countries: An ecological study

Noha Asem, Ahmed Ramadan, Mohamed Hassany et al. · Heliyon · 2021 · 39 citations · Full text

RETRACTED ARTICLE: Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study

Mahmoud El‐Bendary, Sherief Abd‐Elsalam, Tamer Elbaz et al. · Expert Review of Anti-infective Therapy · 2021 · 35 citations